Advisory Research’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding GHDX
BBA
Advisory Research's GHDX Position: Q2 2019 in Review
Advisory Research sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 7,855 shares — an estimated $550K sold.
Advisory Research first reported a position in GHDX in Q4 2018 and held it in 2 quarters. The position peaked at $968K in Q4 2018. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.
- Advisory Research reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
- Advisory Research sold 7,855 Genomic Health, Inc. shares in Q2 2019, an estimated $550K.
- Advisory Research first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 2 quarters.
- Advisory Research's Genomic Health, Inc. position peaked at $968K in Q4 2018.
- 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.
Based on Advisory Research's 13F filing for Q2 2019, filed 14 Aug 2019.